Client Result

Infectious Pathogen Diagnostics Technology Commercialization

Project Overview

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

DeciBio Approach

Primary Research

  • Conducted 50 in-depth stakeholder interviews with laboratory directors and hospital policy implementation supervisors in multiple settings across 7 different countries
  • Interviews centered around technology usage, procurement responsibilities, interactions with other stakeholders, purchasing drivers / barriers, product evaluation criteria, pain points and unmet needs, and feedback on the client’s product profile

Quantitative Analysis

  • Built a bottoms-up model of the pathogen screening / surveillance market segmented by technology, geography, setting, pathogen, etc., with 3 distinct model scenarios
At a glance
50
Stakeholder Interviews
5
Model Segmentations
7
Countries Researched and Modelled
Outcomes

Based on research and analysis, DeciBio identified key purchasing stakeholders, outlined testing and purchasing workflows, and recommended commercialization and market development tactics

Timeline

8 weeks

Geographic Scope

U.S., EU

Industry

Clinical Diagnostics

capabilities

Voice-Of-Customer Research

Addressable Market Sizing

Related Client Results
Clinical Diagnostics
Genetic Testing Lab Target Assessment
A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition
Target Identification
Clinical Diagnostics
MRD Monitoring Market Assessment and Strategy
A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering
Biomarker and Diagnostic Strategy
Go-to-Market Strategy
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
IVDR Diagnostics Strategy
A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions